The global dental biomaterials market is projected to experience significant growth, driven by advancements in materials science and technology, rising demand for cosmetic dentistry procedures, and increasing awareness of oral health. The market is expected to reach US$ 13.0 billion by 2031, exhibiting a CAGR of 6.8% from 2022 to 2031.
SINTX Technologies Inc’s (SINT) stock surged over 90% after receiving a patent for its zirconia-toughened alumina surface functionalization methods. This technology promises to enhance medical implants by integrating the properties of silicon nitride, leading to improved osseointegration and bacterial resistance. The company is currently the only FDA-registered producer of implantable silicon nitride, positioning itself as a key player in the biomaterials market.
